En Español | Plain Text Version | Skip Navigation

You are here:  Home > Disorders > Farber's Disease

NINDS Farber's Disease Information Page

Skip secondary menu

Synonym(s):   Ceramidase Deficiency

Table of Contents (click to jump to sections)
What is Farber's Disease?
Is there any treatment?
What is the prognosis?
What research is being done?

Related NINDS Publications and Information

What is Farber's Disease?
Farber’s disease describes a group of inherited metabolic disorders called lipid storage diseases, in which excess amounts of lipids (oils, fatty acids, and related compounds) build up to harmful levels in the joints, tissues, and central nervous system.  The liver, heart, and kidneys may also be affected.  Symptoms are typically seen in the first few weeks of life and include impaired motor and mental ability and difficulty with swallowing.  Other symptoms may include arthritis, swollen lymph nodes and joints, hoarseness, nodules under the skin (and sometimes in the lungs and other parts of the body), chronic shortening of muscles or tendons around joints, and vomiting.  Affected persons may require the insertion of a breathing tube.  In severe cases, the liver and spleen are enlarged.  The disease occurs when both parents carry and pass on the defective gene that regulates the protein sphingomyelin.  Children born to these parents have a 25 percent chance of inheriting the disorder and a 50 percent chance of carrying the faulty gene.  The disorder affects both males and females.

Is there any treatment?

Currently there is no specific treatment for Farber’s disease.  Corticosteroids can help relieve pain.  Nodes can be treated with bone marrow transplants, in certain instances, or may be surgically reduced or removed.

What is the prognosis?

Most children with the classic form of Farber’s disease die by age 2, usually from lung disease.  Individuals having a milder form of the disease may live into their teenage years.

What research is being done?

The National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), conducts research about lipid storage diseases such as Farber’s disease in laboratories at the NIH and also supports additional research through grants to major medical institutions across the country.

The National Library of Medicine (NLM), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, offers free searches of biomedical literature through an Internet service called PubMed.  Go to:   www.ncbi.nlm.nih.gov/PubMed.  The NLM also offers extensive health information from NIH and other trusted sources.  Go to: www.medlineplus.gov.

Select this link to view a list of studies currently seeking patients.

Related NINDS Publications and Information


Prepared by:
Office of Communications and Public Liaison
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, MD 20892



NINDS health-related material is provided for information purposes only and does not necessarily represent endorsement by or an official position of the National Institute of Neurological Disorders and Stroke or any other Federal agency. Advice on the treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient's medical history.

All NINDS-prepared information is in the public domain and may be freely copied. Credit to the NINDS or the NIH is appreciated.

Return to top

Last updated August 13, 2008